Skip to main content

PDS Biotechnology Corp

PDSB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001472091

No open-market purchases or sales by PDS Biotechnology Corp insiders were filed in the last 90 days; 52 institutions reported holding it in 13F filings for Q2 2026, worth $6.78M in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding PDS Biotechnology Corp changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of PDSB: Q2 2022 compared with Q3 2022
MeasureQ2 2022Of which not filed for Q3 2022Q3 2022Change
Holders52147−4
Shares5.37M10.0K5.18M−181.6K (−3.4%)
Value$19.7M$37.0K$15.4M−$4.28M (−21.8%)

1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (9)

Institutions that held PDS Biotechnology Corp at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to PDSB in Q3 2022
InstitutionSharesValue% of portfolio
Jacobs Levy Equity Management, Inc57,651$171.0K0.00%
Cubist Systematic Strategies, LLC26,302$78.0K0.00%
Jane Street Group, LLC23,162$69.0K0.00%
D. E. Shaw & Co., Inc.14,904$44.0K0.00%
Tower Research Capital LLC (TRC)13,991$42.0K0.00%
EP Wealth Advisors, LLC10,000$30.0K0.00%
UBS Group AG9,883$30.0K0.00%
Federated Hermes, Inc.1,035$3.00K0.00%
TCI Wealth Advisors, Inc.100$00.00%

Sold out (13)

Institutions that held PDS Biotechnology Corp at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of PDSB in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Millennium Management LLC150,497$549.0K
Bank of Montreal43,500$249.0K
Virtu Financial LLC47,326$173.0K
Oppenheimer & Co Inc22,250$81.0K
XTX Topco Ltd21,085$77.0K
Trexquant Investment LP15,151$55.0K
Simplex Trading, LLC13,426$49.0K
Cetera Investment Advisers10,865$40.0K
Quantbot Technologies LP4,200$15.0K
Total Clarity Wealth Management, Inc.3,779$14.0K
National Bank of Canada2,200$8.00K
Cutler Group LP800$2.00K
Captrust Financial Advisors250$1.00K

Not filed for Q3 2022 yet (1)

Institutions that held PDS Biotechnology Corp at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding PDSB in Q2 2022 that haven't filed for Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Minot Wealth Management LLC10,000$37.0K